Related references
Note: Only part of the references are listed.The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia
Donald C. Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Robin M. Murray et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era
M. Alvarez-Jimenez et al.
CNS DRUGS (2016)
The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
Marc De Hert et al.
CNS DRUGS (2015)
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
Harvey A. Whiteford et al.
LANCET (2013)
The evidence for illness progression after relapse in schizophrenia
Robin Emsley et al.
SCHIZOPHRENIA RESEARCH (2013)
Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy Long-term Follow-up of a 2-Year Randomized Clinical Trial
Lex Wunderink et al.
JAMA PSYCHIATRY (2013)
Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
Stefan Leucht et al.
LANCET (2012)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: Results from an aborted randomised trial
Geartsje Boonstra et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2011)
Relapse Prevention in First-Episode Schizophrenia-Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention: Results of a Randomized Controlled Trial Within the German Research Network on Schizophrenia
Wolfgang Gaebel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Robert W. Buchanan et al.
SCHIZOPHRENIA BULLETIN (2010)
Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial
Eric Y. H. Chen et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Guide discontinuaton vesus maintenance treatment in remitted first-episode psychosis: Relapse rates and functional outcome
Lex Wunderink et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Epidemiology of schizophrenia: Review of findings and myths
Erick L. Messias et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)
Antipsychotic medication adherence in schizophrenia
Matthew J. Byerly et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2007)
Pharmacological treatments for first-episode schizophrenia
DG Robinson et al.
SCHIZOPHRENIA BULLETIN (2005)
A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis
P Oosthuizen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Risperidone, 2 mg/day vs. 4 mg/day, in first-episode, acutely psychotic patients: Treatment efficacy and effects on fine motor functioning
MCG Merlo et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies
W Gaebel et al.
SCHIZOPHRENIA RESEARCH (2002)
Share Paper
